Dr Jessica Rose and Dr Peter McCullough have a new paper forthcoming examining myocarditis events, as reported in the US VAERS system for the recording of adverse vax effects. It was uncovered that myocarditis rates were significantly higher in youths between the ages of 13 to 23, with approximately 80 percent occurring in males. It only took eight weeks after the vax rollout for the 12-15-year-old age group, to produce 19 times the expected number of myocarditis cases in the vaccination volunteers relative to background myocarditis rates for this age group. Worse still, a 5-fold increase in myocarditis rate was observed after dose 2 as opposed to dose 1 in 15-year-old males. They conclude that these findings suggest a markedly higher risk for myocarditis after the Covid vax, than for other known vaccines.